Chimeric antigen receptor T-cell immunotherapy for cancer

Use of the body’s immune system in fighting cancer has attracted much research attention over the past few years. Specifically, different approaches such as checkpoint inhibitors and chimeric antigen receptor T-cell have been shown to be effective in killing tumour cells and controlling cancer.   In the case of chimeric antigen receptor T-cell (CART), a … More Chimeric antigen receptor T-cell immunotherapy for cancer